Highlights
-
Today’s Research Article: PRP delivers twice the healing at six months compared to steroids — and helps patients avoid surgery.
-
Questions from the Field: When your results are better, your price should be too — charge for the quality and outcomes you deliver.
-
Let’s Get Down to Business: If patients can’t find you online, they’ll never book — make digital marketing your best closer.
-
Come Join Us: Level up your skills and network with the best at these must-attend orthobiologics events!
If this newsletter was forwarded to you and you'd like to receive future updates directly, subscribe here.
Today’s Research Article
Autologous Platelet‐rich Plasma versus Corticosteroid in the Management of Elbow Epicondylitis: A Randomized Study
Ankit Varshney, Rajesh Maheshwari, Anil Juyal, Atul Agrawal, Prabhnoor Hayer
Summary:
In this randomized study by Varshney et al., 112 patients with elbow epicondylitis were treated with either a corticosteroid injection or autologous platelet-rich plasma (PRP) injection and followed for six months. Both groups showed comparable pain and function improvement at 1 and 2 months, but significant differences emerged later: at 6 months, PRP patients had a 91% improvement in pain scores compared to 42.2% in the steroid group, and a 54.4% improvement in function scores versus only 1.25% with steroids. Importantly, no complications such as infections were reported, although mild post-injection pain was noted.
The findings suggest that while corticosteroids provide short-term relief, PRP leads to superior and longer-lasting improvements by promoting true healing at the tendon level. PRP offers a regenerative treatment approach, whereas steroids mainly suppress inflammation temporarily and may cause structural tendon changes over time. The study concludes that PRP should be considered as a primary nonsurgical option for managing elbow epicondylitis, especially for patients who seek durable recovery without the risks of tendon degeneration.
Talking Points for Doctors to Patients: Why Choose PRP
